State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
Frequently Asked Questions — Clinical Trials in Connecticut
How many clinical trials are currently recruiting in Connecticut?
ClinicalMetric currently tracks 201 actively recruiting clinical trials with at least one location in Connecticut. The total number of registered studies—including active but not currently enrolling trials—is 201. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Connecticut?
Connecticut hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Alcohol Use Disorder, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Connecticut serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Connecticut?
To join a clinical trial in Connecticut, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Connecticut maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Connecticut
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05810259 N/A
Recruiting
Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of ...
Condition
Wellness
Enrollment
120 pts
Location
United States
Sponsor
Yale University
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07228117 N/A
Recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adult...
Condition
Type 1 Diabetes Mellitus
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Medtronic MiniMed, Inc.
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT06667908 Phase 2
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolida...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Johnson & Johnson Enterprise I
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT04177914 Phase 3
Recruiting
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Condition
Hydrocephalus
Enrollment
176 pts
Location
United States, Canada
Sponsor
University of Utah
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05573126 Phase 1, Phase 2
Recruiting
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients...
Condition
Hormone Receptor-positive Breast Cancer
Enrollment
95 pts
Location
United States, Spain, United Kingdom
Sponsor
Ellipses Pharma
NCT05972018 Phase 4
Recruiting
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in ...
Condition
Aortic Aneurysm, Abdominal
Enrollment
14 pts
Location
United States
Sponsor
Hartford Hospital
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT05647122 Phase 1
Recruiting
First in Human Study of AZD9592 in Solid Tumors
Condition
Advanced Solid Tumours
Enrollment
403 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT05675735 N/A
Recruiting
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Rete...
Condition
Problems Related to Social Environment
Enrollment
318 pts
Location
United States
Sponsor
NYU Langone Health
NCT03832361 Phase 2
Recruiting
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-...
Condition
Endometrial Cancer
Enrollment
50 pts
Location
United States
Sponsor
Alessandro Santin
NCT05238922 Phase 1
Recruiting
Study of INCB123667 in Subjects With Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
604 pts
Location
United States, France, Italy
Sponsor
Incyte Corporation
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT03803423 N/A
Recruiting
Dissemination of the Donor Application: Utilizing Social Media to Identify Poten...
Condition
End Stage Renal Disease
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
Page 1 of 9 — 201 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology